ser experience study of digital tools to collect data on wellbeing and side effects in cancer patients
- Conditions
- Cancer10027655
- Registration Number
- NL-OMON53241
- Lead Sponsor
- Antoni van Leeuwenhoek Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 12
Inclusion Criteria
1. Screening for participation in a phase 1-2 anticancer drug trials.
2. Written informed consent to participate in the study.
Exclusion Criteria
1. Not capable of using mobile phone applications, or no carer who is willing
to and able to use the applications on the participants behalf.
2. Enrolled in a phase 1-2 anticancer drug trial that includes a QoL
questionnaire, where inclusion of an additional QoL would interfere with the
study*s intended QoL measurements. This is at the investigator*s discretion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To evaluate the feasibility of using digital tools to report effects of drugs<br /><br>in patients on phase 1 or 2 anticancer drug trials.</p><br>
- Secondary Outcome Measures
Name Time Method <p>To evaluate user experience of using different digital tools to self-report on<br /><br>adverse events and quality of life.</p><br>